MDT

Medtronic

--(--)

Market Open: --

--(--)

Post-Market: --

Signals Analysis

Buy signal 2

Sell signal 1

ample liquidity

High Gross Profit Margin

EPS Below Expectations

Key Stats

--DAY`S RANGE--

--52 WK RANGE--

Open

Prev.Close

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

Low

52 Week High

52 Week Low

About MDT

Medtronic Plc

A leading global healthcare technology company that develops implantable cardiac devices, surgical robotics, insulin pumps, and surgical tools

Industry

Healthcare Equipment and Supplies

Established Date

Invalid Date

Listing Date

01/27/2015

Exchange

New York Stock Exchange

Full-time Employees

95000

Fiscal Year Ends

04-30

Website

www.medtronic.com

Security Type

Common stock

Office address

20 On Hatch, Lower Hatch Street, Dublin 2, Ireland

Business

Research and manufacture of medical equipment or services related to heart, vascular group, minimally invasive therapy, reparative therapy, diabetes, etc

Introduction

Founded in 1949, Medtronic Public Limited Company is the successor registered company of Medtronic, Inc., Minnesota. Medtronic, Inc., was incorporated in Ireland as a private limited liability company on June 12, 2014, and re-registered as a public limited liability company on January 26, 2015. The company was established to facilitate the acquisition of Covidien, a public limited company incorporated under the laws of Ireland (Covidien), which closed on 26 January 2015 (the date of acquisition). Medtronic Public Limited Company, headquartered in Dublin, Ireland, Medtronic, Inc. is one of the world's largest medical technology, services and solutions companies, reducing pain, restoring health and prolonging life for millions of people around the world. Today, it serves hospitals, doctors, clinicians and patients in more than 150 countries around the world. The Company's major customers include hospitals, clinics, third-party healthcare providers, distributors and others, including government healthcare programs and Group Purchasing Organizations (GPOs).

Company Financials

EPS

MDT has released its 2025 Q3 earnings. EPS was reported at 1.39, versus the expected 1.36, beating expectations. The chart below visualizes how MDT has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

MDT has released its 2025 Q3 earnings report, with revenue of 8.29B, reflecting a YoY change of 2.51%, and net profit of 1.30B, showing a YoY change of -2.54%. The Sankey diagram below clearly presents MDT’s revenue sources and cost distribution.